Mayne Pharma Group Ltd.ASX: MYX

Mayne Pharma reports unaudited Q1 FY27 results

· Issued by Mayne Pharma Group Ltd. via ASX

Filed with ASX · · 8 pages · English

On 6ix: 6ix.com/news/mayne-pharma-reports-unaudited-q1-fy27-results

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call

Release

ASX Announcement MAYNE PHARMA REPORTS UNAUDITED FIRST QUARTER FY27 RESULTS 1 Key Points 2 • Executing Women’s Health growth strategy with strong demand growth in 1Q FY27: total prescriptions (TRx) for BIJUVA® up 25% versus the pcp, IMVEXXY® up 13% and NEXTSTELLIS® demand cycles up 27%; •...

Mayne Pharma Group Ltd. on 6ix

In the deck

Story so far

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases